Metabolic reprogramming in lung cancer and its clinical implication.
Qingqiu Huang1, Lisha Fan2, Mingjing Gong3
1Department of Thoracic Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Frontiers in Pharmacology
|January 2, 2025
Summary
This review explores how lung cancer cells reprogram their metabolism to fuel growth. Understanding these metabolic shifts offers new therapeutic strategies for lung cancer treatment.
Area of Science:
- Oncology
- Cancer Metabolism
Background:
- Lung cancer remains a major global health challenge.
- Metabolic reprogramming is crucial for lung cancer cell proliferation and survival.
Purpose of the Study:
- To review recent advancements in understanding lung cancer metabolism.
- To highlight the role of metabolic reprogramming in lung cancer development and treatment.
Main Methods:
- Literature review of recent studies on lung cancer metabolism.
- Analysis of metabolic products and enzymes in lung cancer.
- Examination of targeted metabolic therapies for lung cancer.
Main Results:
- Metabolic reprogramming supports lung cancer cell proliferation.
- Metabolic products and enzymes significantly impact lung cancer occurrence and progression.
- Targeting metabolic pathways shows promise for lung cancer treatment.
Conclusions:
- Understanding lung cancer metabolism is key to developing effective therapies.
- Further research into metabolic reprogramming can uncover novel treatment strategies.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K